Rare CNS manifestation of high-risk CLL with excellent response to triplet targeted therapy

Anusha Swaminathan, Shrinidhi Nathany, Surbhi Singh, Aastha Gupta, Ishita B Sen, Paritosh Garg, Aakriti kothari, Kanika Verma, Vikas Dua, Rahul Bhargava

doi:10.1016/j.lrr.2026.100597

CrossrefKarta ta’ informazzjoni

Rare CNS manifestation of high-risk CLL with excellent response to triplet targeted therapy

Anusha Swaminathan, Shrinidhi Nathany, Surbhi Singh, Aastha Gupta, Ishita B Sen, Paritosh Garg, Aakriti kothari, Kanika Verma, Vikas Dua, Rahul Bhargava

Leukemia Research Reports · 2026 · 26 · 100597

DOI: 10.1016/j.lrr.2026.100597 ↗

Astratt Dettalji biblijografiċi

Astratt

Ebda abstract disponibbli.

Dettalji biblijografiċi

Awturi/Awturiċi: Anusha Swaminathan, Shrinidhi Nathany, Surbhi Singh, Aastha Gupta, Ishita B Sen, Paritosh Garg, Aakriti kothari, Kanika Verma, Vikas Dua, Rahul Bhargava
Ġurnal: Leukemia Research Reports
Sena tal-pubblikazzjoni: 2026
Volum / Ħarġa: 26
Paġni: 100597
Pubblikatur: Elsevier BV
DOI: 10.1016/j.lrr.2026.100597
ISSN: 2213-0489
Sors: Crossref

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.